Johnson & Johnson said recent tests showed that Johnson’s Baby Powder was free of asbestos, after FDA investigations reported trace amounts of the material in the product earlier in 2019.
Johnson & Johnson said recent tests showed that Johnson’s Baby Powder was free of asbestos, after FDA investigations reported trace amounts of the material in the product earlier in 2019.
Tokyo-based Astellas Pharma announced plans to acquire San Francisco-based Audentes Therapeutics for $60 per share in cash, representing a total equity value of about $3 billion.
Seattle Genetics is looking for a quicker path to resolution with Daiichi Sankyo over antibody drug conjugate technology that both companies claim ownership of.
Powder Keg: FDA bowed to industry for decades as alarms were sounded over talc
Asbestos, Business, Cancer Prevention Coalition, Consumers, Cosmetics, Department Of Justice, FDA, FDA/Regulatory, Food Safety and Applied Nutrition (JIFSAN), Health Concerns, Lawsuits, Minerals, Talc, Talc-Based Products, U.S. Securities and Exchange Commission (SEC), World Health OrganizationOver the past 50 years, the FDA has relied upon – and often deferred to – industry even as outside experts and consumers repeatedly raised serious health concerns about talc powders and cosmetics, a Reuters investigation found.
Vaccines: A Healthcare Revolution and High Return on Investment
Business, Chickenpox Virus, Clinical Trials, Deals, Dengue Fever, Diphtheria, Diseases, Haemophilus influenza type B, Hepatitis A, Hepatitis B, Infectious Diseases, Influenza, Measles, Mumps & Rubella, pertussis, Pharmaceutical Research and Manufacturers of America (PhRMA), PhRMA, Pneumococcal Disease, Polio, Product Pipelines, R&D, Rotavirus, Smallpox, tetanus, U.S. Centers for Disease Control and Prevention, Vaccines, Viruses, Whooping Cough, World Health OrganizationAccording to the Pharmaceutical Research and Manufacturers of America (PhRMA), there are 264 vaccines in development to prevent and treat diseases.
The chief executive officer of OxyContin-maker Purdue Pharma LP should not collect a potential $1.3 million bonus when he has been accused of contributing to the opioid epidemic, a group of state attorneys general said in a court filing.
Medical supply company Baxter International agreed to buy Sanofi’s Seprafilm unit, which makes specialist surgical products, for $350 million in cash.
In light of the Thanksgiving season, here are six things about biopharma that the industry is thankful for.
Bio Buzz selected five women venture capitalists who are considered “trailblazing investors shaping the future of life science investing” in the BioCapital Hotbed Community.
